Cancer has many escape routes, but we’re closing off some important ones.
Cancer has many escape routes, but we’re closing off some important ones.
Blocking Escape to Stop Cancer
Anji Onco, a subsidiary of Anji Pharma, is laser-focused on blocking escape routes cancer uses to evade therapeutic intervention. These survival mechanisms - from amplifying a gene that promotes cancer survival, to displaying proteins that cloak cancer cells and hide them from the immune system - diminish the efficacy of even the most powerful anti-cancer drugs. Our unwavering belief is that resistance can be overcome.